Sukalo Maja, Fiedler Ariane, Guzmán Celina, Spranger Stephanie, Addor Marie-Claude, McHeik Jiad N, Oltra Benavent Manuel, Cobben Jan M, Gillis Lynette A, Shealy Amy G, Deshpande Charu, Bozorgmehr Bita, Everman David B, Stattin Eva-Lena, Liebelt Jan, Keller Klaus-Michael, Bertola Débora Romeo, van Karnebeek Clara D M, Bergmann Carsten, Liu Zhifeng, Düker Gesche, Rezaei Nima, Alkuraya Fowzan S, Oğur Gönül, Alrajoudi Abdullah, Venegas-Vega Carlos A, Verbeek Nienke E, Richmond Erick J, Kirbiyik Ozgür, Ranganath Prajnya, Singh Ankur, Godbole Koumudi, Ali Fouad A M, Alves Crésio, Mayerle Julia, Lerch Markus M, Witt Heiko, Zenker Martin
Institute of Human Genetics, University Hospital Magdeburg, Magdeburg, Germany.
Hum Mutat. 2014 May;35(5):521-31. doi: 10.1002/humu.22538. Epub 2014 Apr 9.
Johanson-Blizzard syndrome (JBS) is a rare, autosomal recessive disorder characterized by exocrine pancreatic insufficiency, typical facial features, dental anomalies, hypothyroidism, sensorineural hearing loss, scalp defects, urogenital and anorectal anomalies, short stature, and cognitive impairment of variable degree. This syndrome is caused by a defect of the E3 ubiquitin ligase UBR1, which is part of the proteolytic N-end rule pathway. Herein, we review previously reported (n = 29) and a total of 31 novel UBR1 mutations in relation to the associated phenotype in patients from 50 unrelated families. Mutation types include nonsense, frameshift, splice site, missense, and small in-frame deletions consistent with the hypothesis that loss of UBR1 protein function is the molecular basis of JBS. There is an association of missense mutations and small in-frame deletions with milder physical abnormalities and a normal intellectual capacity, thus suggesting that at least some of these may represent hypomorphic UBR1 alleles. The review of clinical data of a large number of molecularly confirmed JBS cases allows us to define minimal clinical criteria for the diagnosis of JBS. For all previously reported and novel UBR1 mutations together with their clinical data, a mutation database has been established at LOVD.
约汉森-布莱兹德综合征(JBS)是一种罕见的常染色体隐性疾病,其特征为外分泌胰腺功能不全、典型面部特征、牙齿异常、甲状腺功能减退、感音神经性听力损失、头皮缺损、泌尿生殖系统和肛门直肠异常、身材矮小以及不同程度的认知障碍。该综合征由E3泛素连接酶UBR1缺陷引起,UBR1是蛋白水解N端规则途径的一部分。在此,我们回顾了先前报道的(n = 29)以及来自50个无关家庭患者中总共31个与相关表型有关的新型UBR1突变。突变类型包括无义突变、移码突变、剪接位点突变、错义突变和框内小缺失,这与UBR1蛋白功能丧失是JBS分子基础的假设一致。错义突变和框内小缺失与较轻的身体异常和正常智力相关,因此表明其中至少一些可能代表亚效性UBR1等位基因。对大量分子确诊的JBS病例临床数据的回顾使我们能够确定JBS诊断的最低临床标准。对于所有先前报道的和新型UBR1突变及其临床数据,已在LOVD建立了一个突变数据库。